San Raffaele
| イタリア | トルコ | オーストリア | |
| 肝動脈内放射線療法 | から $45,000 | から $17,820 | から $35,000 |
Bookimedは肝動脈内放射線療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで肝動脈内放射線療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。肝動脈内放射線療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。肝動脈内放射線療法の旅路でお一人になることはありません。
Radioembolization (SIRT) is available in Italy for treating primary liver cancer and colorectal metastases. Leading university hospitals and research institutes in Milan and Rome utilize Yttrium-90 microspheres (SIR-Spheres). These centers provide advanced interventional radiology for patients who are not candidates for surgery.
Bookimed Expert Insight: While Italy hosts top-tier research hospitals like San Raffaele, specialized SIRT availability is regionally concentrated. Large institutes often combine research with care, giving patients access to the latest clinical protocols. Patients should confirm which specific microsphere brand a hospital stocks before traveling for treatment.
Patient Consensus: Patients recommend contacting major centers like the National Cancer Institute directly to confirm current availability. Many suggest considering private options or cross-border care to avoid longer wait times in the public system.
Radioembolization is a two-step outpatient procedure for liver cancer involving a mapping session and Y-90 radioactive bead injection. Interventional radiologists guide a catheter via the groin or wrist into liver blood vessels. Microscopic beads then deliver targeted radiation directly to the tumor.
Bookimed Expert Insight: Italian research centers like San Raffaele in Milan combine clinical care with intensive IRCCS research. This ensures patients access specific technical expertise for complex vessel mapping. Some Italian clinics perform over 52,000 surgeries yearly, providing high volume confidence for this precise intervention.
Patient Consensus: Travelers often highlight that systemic side effects are minimal compared to traditional chemotherapy. Most feel ready for light activity within 1 week despite temporary fatigue or mild abdominal pain.
Radioembolization with Yttrium-90 serves as an effective bridge to liver transplant by controlling tumor growth. This locoregional therapy prevents waitlist dropout and downstages large tumors to meet Milan criteria. It currently surpasses traditional chemoembolization as the most utilized bridging method for hepatocellular carcinoma.
Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan combine clinical assistance with IRCCS research accreditation. Our data shows these centers manage over 52,000 operations annually. They often lead in multidisciplinary reviews for complex bridging cases. This research-heavy environment provides faster access to the latest protocols for patients with high tumor burdens.
Patient Consensus: Treatment can sustain waitlist eligibility for over 18 months by shrinking tumors significantly. Patients advise monitoring liver function closely as post-radiation fatigue can mimic liver failure symptoms.
Italy features world-class centers for radioembolization, specifically in Milan and Rome. Top facilities like San Raffaele Hospital and Policlinico Gemelli utilize multidisciplinary teams. These research-heavy institutions (IRCCS) provide Yttrium-90 (Y90) therapy and advanced SIRT under precise instrumental guidance for complex liver cases.
Bookimed Expert Insight: Data suggests focusing on high-volume hubs like Policlinico Gemelli and San Raffaele. These centers manage 100+ cases yearly. High volume tracks directly with lower post-procedure fatigue rates. At specialized hubs, fatigue drops significantly compared to smaller clinics. Choosing these IRCCS centers ensures access to mandatory national outcome registries.
Patient Consensus: Patients emphasize the importance of the pre-procedure mapping angiogram to prevent delays. Many recommend seeking a second opinion on dosimetry simulations to ensure accuracy.